1127 related articles for article (PubMed ID: 21937200)
121. The molecular pathogenesis of mycosis fungoides and Sézary syndrome.
Döbbeling U
G Ital Dermatol Venereol; 2008 Dec; 143(6):385-94. PubMed ID: 19169211
[TBL] [Abstract][Full Text] [Related]
122. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
Nevala H; Karenko L; Vakeva L; Ranki A
Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
[TBL] [Abstract][Full Text] [Related]
123. Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment.
Alberti-Violetti S; Talpur R; Schlichte M; Sui D; Duvic M
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e105-12. PubMed ID: 25817937
[TBL] [Abstract][Full Text] [Related]
124. CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.
Laharanne E; Chevret E; Idrissi Y; Gentil C; Longy M; Ferrer J; Dubus P; Jouary T; Vergier B; Beylot-Barry M; Merlio JP
Mod Pathol; 2010 Apr; 23(4):547-58. PubMed ID: 20118908
[TBL] [Abstract][Full Text] [Related]
125. Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patients.
López-Lerma I; Peñate Y; Gallardo F; Martí RM; Mitxelena J; Bielsa I; Velasco-Tamariz V; Yanguas-Bayona JI; Sánchez-Sambucety P; García-Patos V; Ortiz-Romero PL; Pujol RM; Estrach T
J Am Acad Dermatol; 2018 Nov; 79(5):892-898. PubMed ID: 30126736
[TBL] [Abstract][Full Text] [Related]
126. Cutaneous lymphoma: Kids are not just little people.
Ferenczi K; Makkar HS
Clin Dermatol; 2016; 34(6):749-759. PubMed ID: 27968935
[TBL] [Abstract][Full Text] [Related]
127. Management of the cutaneous peripheral T-cell lymphomas: when subtypes matter.
Choi MY; Lechowicz MJ
Cancer J; 2012; 18(5):439-44. PubMed ID: 23006949
[TBL] [Abstract][Full Text] [Related]
128. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
[TBL] [Abstract][Full Text] [Related]
129. Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas.
Dommann SN; Dommann-Scherrer CC; Dours-Zimmermann MT; Zimmermann DR; Kural-Serbes B; Burg G
Arch Dermatol Res; 1996 Apr; 288(4):163-7. PubMed ID: 8967786
[TBL] [Abstract][Full Text] [Related]
130. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
Quaglino P; Knobler R; Fierro MT; Savoia P; Marra E; Fava P; Bernengo MG
Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
[TBL] [Abstract][Full Text] [Related]
131. Overview of Cutaneous T-Cell Lymphomas.
Larocca CA; LeBoeuf NR
Hematol Oncol Clin North Am; 2019 Aug; 33(4):669-686. PubMed ID: 31229162
[TBL] [Abstract][Full Text] [Related]
132. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma.
Scarisbrick JJ; Whittaker S; Evans AV; Fraser-Andrews EA; Child FJ; Dean A; Russell-Jones R
Blood; 2001 Feb; 97(3):624-30. PubMed ID: 11157477
[TBL] [Abstract][Full Text] [Related]
133. Expression of helper T cell master regulators in inflammatory dermatoses and primary cutaneous T-cell lymphomas: diagnostic implications.
Hsi AC; Lee SJ; Rosman IS; Carson KR; Kelley A; Viele V; Pang X; Musiek A; Schaffer A
J Am Acad Dermatol; 2015 Jan; 72(1):159-67. PubMed ID: 25440432
[TBL] [Abstract][Full Text] [Related]
134. Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
Zic JA
Med Clin North Am; 2021 Jul; 105(4):737-755. PubMed ID: 34059248
[TBL] [Abstract][Full Text] [Related]
135. Cutaneous peripheral T-cell lymphomas, unspecified/NOS and rare subtypes: a heterogeneous group of challenging cutaneous lymphomas.
Kempf W; Rozati S; Kerl K; French LE; Dummer R
G Ital Dermatol Venereol; 2012 Dec; 147(6):553-62. PubMed ID: 23149701
[TBL] [Abstract][Full Text] [Related]
136. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas.
Merrill ED; Agbay R; Miranda RN; Aung PP; Tetzlaff MT; Young KH; Curry JL; Nagarajan P; Ivan D; Prieto VG; Medeiros LJ; Duvic M; Torres-Cabala CA
Am J Surg Pathol; 2017 Feb; 41(2):204-215. PubMed ID: 27879514
[TBL] [Abstract][Full Text] [Related]
137. Cutaneous T-cell lymphoma: CT in evaluation and staging.
Bass JC; Korobkin MT; Cooper KD; Kane NM; Platt JF
Radiology; 1993 Jan; 186(1):273-8. PubMed ID: 8416579
[TBL] [Abstract][Full Text] [Related]
138. Cutaneous T cell lymphoma: update on treatment.
Wollina U
Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
[TBL] [Abstract][Full Text] [Related]
139. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
[No Abstract] [Full Text] [Related]
140. Primary cutaneous lymphoma in southern Brazil: a 12-year single-center experience.
Nudelmann LM; Bonamigo RR
Int J Dermatol; 2015 Dec; 54(12):e512-20. PubMed ID: 26496535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
